Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study

  1. Poveda, A.
  2. Lopez-Reig, R.
  3. Oaknin, A.
  4. Redondo, A.
  5. Rubio, M.J.
  6. Guerra, E.
  7. Fariñas-Madrid, L.
  8. Gallego, A.
  9. Rodriguez-Freixinos, V.
  10. Fernandez-Serra, A.
  11. Juan, O.
  12. Romero, I.
  13. Lopez-Guerrero, J.A.
Journal:
Cancers

ISSN: 2072-6694

Year of publication: 2022

Volume: 14

Issue: 4

Type: Article

DOI: 10.3390/CANCERS14040915 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus